🏆 Finalist — NIH Data Sharing Index (“S-Index”) Challenge
Demo corpus. Scores are computed on a select set of biomedical paper/datasets and may be inaccurate for papers outside this corpus — DataRank relies on network effects that improve with scale. We aim to expand this into a fully open resource pending additional funding.

Years lived with disability (YLDs) for 1160 sequelae of 289 diseases and injuries 1990–2010: a systematic analysis for the Global Burden of Disease Study 2010

The Lancet(2012)10.1016/s0140-6736(12)61729-2Source: DataRank Database

Years lived with disability (YLDs) for 1160 sequelae of 289 diseases and injuries 1990–2010: a systematic analysis for the Global Burden of Disease Study 2010 is a dataset published in The Lancet (2012). On theSindex it has a DataRank of 10.3, placing it in the top 20.6% of the data-sharing corpus. It has been cited 8,369 times, with 120 citing works in its 1-hop citation network. Its calibrated FAIR score is 65/100.

Top 21%percentile
10.3DataRank
10.3Top 21%
Dataset Open Access8369 citations · base score 9.0
Cite:
datarank_citation_only_1hop_v6· scope data_onlyMethodology

Abstract

BackgroundNon-fatal health outcomes from diseases and injuries are a crucial consideration in the promotion and monitoring of individual and population health. The Global Burden of Disease (GBD) studies done in 1990 and 2000 have been the only studies to quantify non-fatal health outcomes across an exhaustive set of disorders at the global and regional level. Neither effort quantified uncertainty in prevalence or years lived with disability (YLDs).MethodsOf the 291 diseases and injuries in the GBD cause list, 289 cause disability. For 1160 sequelae of the 289 diseases and injuries, we undertook a systematic analysis of prevalence, incidence, remission, duration, and excess mortality. Sources included published studies, case notification, population-based cancer registries, other disease registries, antenatal clinic serosurveillance, hospital discharge data, ambulatory care data, household surveys, other surveys, and cohort studies. For most sequelae, we used a Bayesian meta-regression method, DisMod-MR, designed to address key limitations in descriptive epidemiological data, including missing data, inconsistency, and large methodological variation between data sources. For some disorders, we used natural history models, geospatial models, back-calculation models (models calculating incidence from population mortality rates and case fatality), or registration completeness models (models adjusting for incomplete registration with health-system access and other covariates). Disability weights for 220 unique health states were used to capture the severity of health loss. YLDs by cause at age, sex, country, and year levels were adjusted for comorbidity with simulation methods. We included uncertainty estimates at all stages of the analysis.FindingsGlobal prevalence for all ages combined in 2010 across the 1160 sequelae ranged from fewer than one case per 1 million people to 350,000 cases per 1 million people. Prevalence and severity of health loss were weakly correlated (correlation coefficient -0·37). In 2010, there were 777 million YLDs from all causes, up from 583 million in 1990. The main contributors to global YLDs were mental and behavioural disorders, musculoskeletal disorders, and diabetes or endocrine diseases. The leading specific causes of YLDs were much the same in 2010 as they were in 1990: low back pain, major depressive disorder, iron-deficiency anaemia, neck pain, chronic obstructive pulmonary disease, anxiety disorders, migraine, diabetes, and falls. Age-specific prevalence of YLDs increased with age in all regions and has decreased slightly from 1990 to 2010. Regional patterns of the leading causes of YLDs were more similar compared with years of life lost due to premature mortality. Neglected tropical diseases, HIV/AIDS, tuberculosis, malaria, and anaemia were important causes of YLDs in sub-Saharan Africa.InterpretationRates of YLDs per 100,000 people have remained largely constant over time but rise steadily with age. Population growth and ageing have increased YLD numbers and crude rates over the past two decades. Prevalences of the most common causes of YLDs, such as mental and behavioural disorders and musculoskeletal disorders, have not decreased. Health systems will need to address the needs of the rising numbers of individuals with a range of disorders that largely cause disability but not mortality. Quantification of the burden of non-fatal health outcomes will be crucial to understand how well health systems are responding to these challenges. Effective and affordable strategies to deal with this rising burden are an urgent priority for health systems in most parts of the world.FundingBill & Melinda Gates Foundation.

Data sources & pipeline
Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring
Enrichment:Pending

FAIR Checklist

Context only (not used in score)
Findable (1/2)
  • Has DOI
Accessible (1/2)
  • Open Access
Interoperable (0/2)
    Reusable (1/3)
    • Dataset classification

    FAIR checklist signals are shown for context only and do not affect DataRank scoring.

    65FAIR score
    F Findable
    100
    A Accessible
    70
    I Interoperable
    50
    R Reusable
    42
    Top 4% by FAIRdeterministic✓ full text read

    Calibrated FAIR score — a parallel quality metric, independent of the DataRank citation score. See the full evaluation →

    DataRank Breakdown

    Base Score 13%Citation Network 87%

    Base Score Contribution

    1.4

    From this paper's citation signal

    Citation Network Contribution

    9.0

    From 120 citing papers with measurable signal

    Learn more about DataRank methodology →

    Top 5 citers driving the network score

    Ranked by citation count — the same ordering the engine uses when summing log1p(Cq) over citers.

    Why this DataRank?

    DataRank blends this paper's own citation count with the influence of the papers that cite it. Here, roughly 13% comes from its base citations and 87% from the citation network (120 citing papers contributed measurable signal).

    Base score B(p)
    log1p(citation_count) — grows sub-linearly, so a paper with 1,000 citations is not 10× a paper with 100.
    Network N(p)
    Σ over citers of log1p(Cq) ÷ max(outdegreeq, 1). Being cited by a highly-cited paper with few references counts most.
    Damping factor d = 0.85
    DataRank = (1−d)·B(p) + d·N(p) — the two cards above are each already multiplied by their share.
    Self-citations excluded
    Citers sharing any OpenAlex author ID with this paper are filtered out before the network sum.

    Citers are pulled from OpenAlex sorted by cited_by_count:descand capped per paper, so when the cap binds we keep the highest-signal references and the score is reproducible across reruns.

    Read the full methodology →

    Click a node to highlight its connections. Use scroll to zoom. Drag to pan.

    Node colors:CenterData PaperData + Open AccessNon-dataSelected & links| Node size = percentile rank

    Authors (421)

    Abraham D Flaxman,Mohsen NaghaviORCID,Rafael LozanoORCID,Catherine Michaud,Majid EzzatiORCID

    Related Papers (10)

    The Lancet(2005)
    co-citedsame journal
    10.1016/s0140-6736(05)17741-1
    Diabetes Research and Clinical Practice(2010)
    co-cited
    10.1016/j.diabres.2009.10.007
    Harmonizing the Metabolic Syndrome
    N/A
    1.4DataRank · unranked
    Circulation(2009)
    co-cited
    10.1161/circulationaha.109.192644